Clinical Trial Detail

NCT ID NCT02773524
Title A Study of Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer (INTEGRATEII)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements no
Sponsors Australasian Gastro-Intestinal Trials Group
Indications

stomach carcinoma

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma

Therapies

Regorafenib

Age Groups: senior adult

No variant requirements are available.